Blog
In-depth articles on peptide science, research guides, and industry insights from the Volta Peptides team.

10 Best Canadian Peptide Vendors in 2027
Eight Canadian peptide suppliers scored on six published criteria, with every vendor score, the 0 to 5 anchors, the evidence behind each one and the weighted arithmetic shown. Two of the ten originally reviewed have closed and are listed with the evidence. Reviewed October 21, 2026.

10 Best USA Peptide Providers in 2027
US research suppliers, reference-standard houses, licensed medical services and GMP manufacturers are four different markets, so this comparison ranks them separately on six weighted criteria led by analytical documentation. Every vendor claim was checked against its live site in October 2026.

Where to Buy Peptides in Canada Online: The Ultimate Guide (2027 Edition)
A checkable procedure for evaluating any Canadian peptide supplier: the legal position under Health Canada, what actually happens to a cross-border parcel, how to read a Certificate of Analysis line by line, and the red flags that separate a real supplier from a dropshipper.

Pre-Aliquoting for Peptides: Stability, Convenience, and Workflow Efficiency
Pre-aliquoting peptides before delivery minimizes freeze-thaw cycles, preserves peptide integrity, and saves researchers time. This service is available for custom synthesis of standard peptides, peptide pools, and peptide libraries. Learn how pre-aliquoting enhances stability and streamlines laboratory workflows.

GHK-Cu, KPV, TB-500 and BPC-157 Blend 80mg: Measured Composition and Certificate Data
An 80mg four-component blend with a published certificate: GHK-Cu, KPV, TB-500 and BPC-157, each measured separately. What the certificate reports, how the headline purity is calculated, and what is genuinely not known about the combination.

BPC-157 10mg: Sequence, Analytical Identity and the Shape of the Literature
BPC-157 is a 15-residue synthetic peptide with no cysteine, methionine or tryptophan. Its sequence and registry data, what HPLC and mass spectrometry confirm on a lot, and why its published literature has to be read with its study design in view.

Peptide Synthesis: Solid-Phase and Solution-Phase Methods
Compare solid-phase vs solution-phase peptide synthesis methods, their mechanisms, limitations, and research applications.

Peptide Solubility: Factors, Guidelines, and Research Protocols
Comprehensive guide to peptide solubility factors, guidelines, and research protocols for laboratory use.

Peptide Purity: Standards, Testing and Analytical Methods
Peptide purity standards, analytical methods and testing for research: what HPLC, mass spectrometry and amino acid analysis each establish, and what a purity figure needs beside it to be checkable.

IGF-1 (Insulin-Like Growth Factor 1): Structure, Signaling, and Research Applications
IGF-1 peptide structure, signaling pathways, and preclinical research applications for laboratory investigation.

5-Amino-1MQ: NNMT Inhibition and the NAD+ Salvage Pathway
5-Amino-1MQ is not a peptide. It is a small-molecule quinolinium salt that inhibits nicotinamide N-methyltransferase (NNMT). Its chemical identity, the methyl-transfer reaction it blocks, how that reaction sits beside the NAD+ salvage pathway, and how thin the compound-specific literature is.

What Is a Peptide? Fundamentals of Peptide Structure and Function
Explore peptide fundamentals: structure, function, and research applications. A scientific overview for researchers.

Humanin: A Mitochondrially Encoded Peptide, Its Sequence and Receptor Signalling
Humanin is a 24-residue peptide encoded by the mitochondrial genome rather than the nuclear one. Its sequence and formula, the receptor complex and signalling pathways it is reported to engage in cell culture, the S14G analogue, and why its literature needs careful reading.

Dihexa (PNB-0408): Structure, a Proposed HGF/c-Met Mechanism and a Retracted Literature
Dihexa (PNB-0408) is a synthetic, metabolically stabilised analogue of angiotensin IV. Its structure, the HGF/c-Met mechanism proposed for it, the 2025 retraction of the paper that mechanism rests on, the notice of concern on a second paper, and why almost the whole literature comes from one laboratory.

TB-500 and Thymosin Beta-4: Identity, Actin Binding and the State of the Literature
TB-500 is the seven-residue actin-binding fragment of thymosin beta-4, and the name is used elsewhere for three other molecules. How the certificate identifies the one in the vial, what G-actin sequestration means at the molecular level, and which parts of the literature carry retractions.

How to Read a Certificate of Analysis (COA): The Complete Guide for Peptide Researchers
A working guide to interpreting every section of a peptide Certificate of Analysis, from HPLC chromatograms and mass spec data to spotting the red flags that separate credible documentation from recycled paperwork.

Sermorelin: GHRH(1-29) Structure and Receptor Signalling in Pituitary Cells
Sermorelin is the first 29 residues of the 44-residue growth hormone-releasing hormone, amidated at the C-terminus, and a full agonist at the GHRH receptor. How the receptor couples to Gs, how cyclic AMP and protein kinase A lead to calcium entry, and how calcium drives exocytosis in pituitary cells.

How to Read a Research Peptide Vendor's Terms Before You Order
Six clauses decide almost everything about what happens when a research peptide order goes wrong: governing law, fault returns, risk of loss, customs, the inspection window, and whether the purity figure is a specification or a measurement.

Hexarelin: Structure, GHS-R1a and CD36 Binding, and Receptor Desensitisation
Hexarelin is a synthetic hexapeptide derived from GHRP-6 and an agonist at the ghrelin receptor GHS-R1a. It also binds a second, unrelated site, CD36, identified in 2002 by photoaffinity labelling. Its structure, both binding sites, and the receptor internalisation behind its tachyphylaxis.

Peptide Library Design: Synthesis, Types, and Screening
Synthetic peptide libraries consist of small peptides made through chemical synthesis, with sizes calculated as 20^n using natural amino acids. Cyclic and linear variants support drug discovery, enzyme inhibition, and vaccine development. Screening methods like phage display and ELISA identify high-affinity binders from these libraries.

What Are Targeting Peptides?
A targeting peptide is a short chain of 5 to 30 amino acids that recognises one receptor or tissue marker and acts as an address label for whatever is attached to it. This covers how the binding works, how a peptide is conjugated to a drug or nanoparticle, how cyclisation and D-amino acid substitution raise affinity and stability, and how display screening finds the sequences in the first place.
Showing 21 of 45 posts
